WIPO Patent Law Committee Adopts Work Programme; Good Omen, Some Say 30/06/2016 by Catherine Saez, Intellectual Property Watch 1 Comment World Intellectual Property Organization members attending this week’s patent law committee meeting agreed on a work programme, reflecting divergent views on patents and health, exceptions and limitations, and patent quality.
Africa Regional Group Proposes Patents And Health Programme At WIPO 29/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment This week in the World Intellectual Property Organization patent law committee, the African Group submitted an updated proposal for a work programme on patents and health that would help developing countries tailor patent law to their circumstances.
WIPO Patent Law Committee Undertakes Many Issues This Week 27/06/2016 by William New, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization Committee on the Law of Patents (SCP) is meeting this week. Among the possible agenda items: updates to the international patent system, exceptions and limitations to patents, quality of patents, patents and health, confidentiality of client-patent advisor communications, and technology transfer. A recent developed country proposal relates to increased work-sharing among patent offices. Also on the table this week is a new proposal to study the assessment of inventive step by patent practitioners.
LinkedIn’s Patent Portfolio; Looking For Hidden Gems 23/06/2016 by Intellectual Property Watch 2 Comments John Sullivan writes: It’s obvious that this acquisition isn’t necessarily about the IP assets of LinkedIn. However, let’s have a closer look at LinkedIn’s portfolio to see if there are any hidden gems inside that would represent a nice fringe benefit to what already looks like a mutually beneficial acquisition.
US High Court Inter Partes Review Leaves Patent Holders Dissatisfied 21/06/2016 by Dugie Standeford for Intellectual Property Watch 1 Comment A 20 June decision by the Supreme Court upholding US Patent and Trademark Office (USPTO) rules for inter partes review of patents isn’t helpful to patent owners, according to several attorneys. The ruling in Cuozzo Speed Technologies, LLC v. Lee (No. 15-446) disappointed expectations for another pro-patent holder decision following a 13 June ruling in another case, said Proskauer patent lawyer Baldassare Vinti. USPTO Director Michelle Lee, however, said the decision would allow the office to continue resolving patentability disputes via less expensive alternatives to litigation.
UN Development Agency Issues Guidelines For Pharmaceutical Patent Examiners 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.
Industry, Researchers Make Case For Patents And Innovation At WTO 09/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Panellists at a side event this week at the World Trade Organization reminded delegates of the view that patents and a strong innovative environment are key to innovation, and in particular to green technology. A Swiss start-up company developing a technology allowing industrial farmers to optimise their use of chemicals and pesticides said it would […]
US Blindsides Allies Over Patents And Genetic Resources At WIPO 05/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The United States may have hoped for a different result last week when it alienated allies at the World Intellectual Property Organization by issuing a rash criticism of Switzerland’s policy on patents and genetic resources and threatened to follow with more.
Q&A With Erich Spangenberg On Patents And Drug Prices 03/06/2016 by Intellectual Property Watch 1 Comment Prices for drugs have long been a problem for developing countries but now have become out of reach for many in developed countries, sparking policy debates and efforts to address it. One of the top figures in the patent monetization business, industry maverick Erich Spangenberg offers a lively opinion on the underlying problem and how to fix it. To start? Stop granting patent extensions for minor changes.
At WIPO, US Plays Hypotheticals With Swiss Law On Disclosure Of Genetic Resources In Patents 02/06/2016 by Catherine Saez, Intellectual Property Watch 1 Comment With discussions in full swing at the World Intellectual Property Organization on how to protect genetic resources in intellectual property rights, and in particular whether the disclosure of the source of genetic resources should be mandatory in patent applications, the United States has tabled a document hypothetically applying the mandatory disclosure legislation of Switzerland to a US patent.